1. Mahmoodi P, Fani M, Rezayi M, Avan A, Pasdar Z, Karimi E, et al. Early detection of cervical cancer based on high‐risk HPV DNA‐based genosensors: A systematic review. Biofactors 2019; 45(2): 101-17.

2. Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, et al. Cervical cancer, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2019; 17(1): 64-84.

3. Riahi S, Mokhtari AM, Vali M, Abdzadeh E, Mohseni S, Salehiniya H, et al. The incidence and mortality rate of cervix cancer in Iran from 1990 to 2016: A systematic review and meta-analysis Running title: Cervix cancer in Iran. J Contemp Med Sci 2019; 5(1): 315-20.

4. Taib S, Ismail N, Mat SN, Shah SA. A Systematic review on factors associated with cervical cancer screening among immigrant women. Int J Pub Hea Cli Sci 2019; 6(1): 22-33.

5. Sekhon S, Kuroki L, Colditz G. Do cancer survivors understand their risk factors for recurrence and the value of coordinated care between an oncologist and a primary care physician? A survey of endometrial and cervical cancer patients. J Clin Transl Sci 2019; 3(1): 121-7.

6. Fokdal L, Tanderup K, Pötter R, Sturdza A, Kirchheiner K, Chargari C, et al. Risk Factors for Ureteral Stricture After Radiochemotherapy Including Image Guided Adaptive Brachytherapy in Cervical Cancer: Results From the EMBRACE Studies. Int J Rad Onc Bio Phy 2019; 103(4): 887-94.

7. Wu J, Ye T, Lv J, He Z, Zhu J. Laparoscopic nerve-sparing radical hysterectomy vs laparoscopic radical hysterectomy in cervical cancer: a systematic review and meta-analysis of clinical efficacy and bladder dysfunction. J Min Inv Gyn 2019; 26(3): 417-26. e6.

8. Prasher P, Mudila H, Sharma M, Khati B. Developmental perspectives of the drugs targeting enzyme-instigated inflammation: a mini review. Med Chem Res 2019; 28(4): 417-49.

9. Jenkins R, Hibberd M. Novel pharmaceutical uses. Google Patents 2019; 20(2): 312-316

10. Küçükgüzel ŞG, Koç D, Çıkla‐Süzgün P, Özsavcı D, Bingöl‐Özakpınar Ö, Mega‐Tiber P, et al. Synthesis of Tolmetin Hydrazide–Hydrazones and Discovery of a Potent Apoptosis Inducer in Colon Cancer Cells. Archiv Der Pharmazie 2015; 348(10): 730-42.

11. Dangi AK, Sinha R, Dwivedi S, GUPTA SK, Shukla PS. Cell line techniques and gene editing tools for antibody production: A review. Front Pharmacol 2018; 26(9): 630.

12. Liu T, Liang H, Liu L, Gong Y, Ding Y, Liao G, et al. Influence of pristine and hydrophobic ZnO nanoparticles on cytotoxicity and endoplasmic reticulum (ER) stress-autophagy-apoptosis gene expression in A549-macrophage co-culture. Ecotoxicol Environ Saf 2019; 167(1): 188-95.

13. Schuetz JM, Grundy A, Lee DG, Lai AS, Kobayashi LC, Richardson H, et al. Genetic variants in genes related to inflammation, apoptosis and autophagy in breast cancer risk. PloS one 2019; 14(1): 812-6.

14. Ghosh AK. Anti-cancer agents and preparation thereof. Google Patents 2019; 12(6): 314-18.

15. La CV, Tavani A, Garattini S. Adverse effects of preventive therapy in humans. IARC Sci Publ 1996(139): 135-42.

16. Tomisato W, Tanaka K-i, Katsu T, Kakuta H, Sasaki K, Tsutsumi S, et al. Membrane permeabilization by non-steroidal anti-inflammatory drugs. Biochem Biophys Res Commu 2004; 323(3): 1032-9.

17. Neill AS, Nagle CM, Protani MM, Obermair A, Spurdle AB, Webb PM, et al. Aspirin, nonsteroidal anti‐inflammatory drugs, paracetamol and risk of endometrial cancer: A case–control study, systematic review and meta‐analysis. Int J Cancer 2013; 132(5): 1146-55.

18. Seely D, Wu P, Fritz H, Kennedy DA, Tsui T, Seely AJ, et al. Melatonin as adjuvant cancer care with and without chemotherapy: a systematic review and meta-analysis of randomized trials. Integr Cancer Ther 2012; 11(4): 293-303.

19. Grabosch SM, Shariff OM, Wulff JL, Helm CW. Non‐steroidal anti‐inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia. Cochrane Database Syst Rev 2014; 10(4): 2015-220.

20. Fong W, To KK. Drug repurposing to overcome resistance to various therapies for colorectal cancer. Cell Mol Life Sci 2019; 20(6): 1-24.

21. Wong RS. Role of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Cancer Prevention and Cancer Promotion. Adv Pharmacol Sci 2019; 32(6): 1-9.

22. Qi L, Ye J, Xue W, Tian X, Zhang H. The mechanism of aspirin combined with metformin induced apoptosis of thyroid cancer TPC-1 cells. Chi jou onc 2019; 41(4): 276-81.

23. Bigdeli R, Shahnazari M, Panahnejad E, Cohan RA, Dashbolaghi A, Asgary V. Cytotoxic and apoptotic properties of silver chloride nanoparticles synthesized using Escherichia coli cell-free supernatant on human breast cancer MCF 7 cell line. Artif Cells Nanomed Biotechnol 2019; 47(1): 1603-9.

24. Rong Z, Xu Y, Zhang C, Xiang D, Li X, Liu D. Evaluation of intestinal absorption of amtolmetin guacyl in rats: breast cancer resistant protein as a primary barrier of oral bioavailability. Life Sci 2013; 92(3): 245-51.

25. Bellosillo B, Piqué M, Barragán M, Castaño E, Villamor N, Colomer D, et al. Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells. Blood 1998; 92(4): 1406-14.

26. He Q, Luo X, Huang Y, Sheikh MS. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells. Oncogene 2002; 21(39): 6032-26.